Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Integrative analysis of TP73 profile prognostic significance in WHO grade II/III glioma.

Cancer medicine - 1 Jul 2021

Chen Yanming, Wang Ye, He Qiheng, Wang Wen, Zhang Tan, Wang Zhongyong, Dong Jun, Lan Qing, Zhao Jizong

Abstract excerpt

Due to the extremely intrinsic heterogeneity among glioma patients, the outcomes of these patients are tremendously different. Therefore, the exploitation of novel biomarker classification of glioma is vitally important for deep insight into the essence and predicting the prognosis of glioma. We aim to analyze the correlation between TP73 mRNA expression, DNA methylated alteration and the prognosis of WHO grade...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Brain Neoplasms
Share to Chromosomes, Human, Pair 1

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Glioma

Share to Neoplasm Grading

Share to Progression-Free Survival

Share to Proportional Hazards Models

Share to Tumor Protein p73

Share to World Health Organization

Source

Open in PubMed Open full text

Identifiers

PMID: 34121368
DOI: 10.1002/cam4.4016
PMCID: PMC8267133

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-07.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Integrative analysis of TP73 profile prognostic significance in WHO grade II/III glioma.PMID 34121368Read ↗

TP53I13 promotes metastasis in glioma via macrophages, neutrophils, and fibroblasts and is a potential prognostic biomarkerSemantic proximity Read ↗

A model of molecular characteristics to classify patients with WHO Grade III gliomasSemantic proximity Read ↗

IDH/MGMT-driven molecular classification of low-grade glioma is a strong predictor for long-term survival.Semantic proximity Read ↗

Identification of a Four-miRNA Risk Score Model and Hub Genes as a Novel Potential Prognostic Biomarker in Patients with GliomaSemantic proximity Read ↗

Comprehensive Molecular Analyses of a Novel Mutational Signature Classification System with Regard to Prognosis, Genomic Alterations, and Immune Landscape in GliomaSemantic proximity Read ↗

[Advances of glioma biomarkers].Semantic proximity Read ↗

Clinical significance of the 2016 WHO classification in Japanese patients with gliomas.Semantic proximity Read ↗

Prognostic value of a nine-gene signature in glioma patients based on mRNA expression profiling.Semantic proximity Read ↗

A new prognostic scoring scale for patients with primary WHO grade III gliomas based on molecular predictors.Semantic proximity Read ↗

Identification of Core Biomarkers Associated with Outcome in Glioma: Evidence from Bioinformatics AnalysisSemantic proximity Read ↗

Molecular classification of IDH-mutant glioblastomas based on gene expression profilesSemantic proximity Read ↗

Molecular classification of diffuse cerebral WHO grade II/III gliomas using genome- and transcriptome-wide profiling improves stratification of prognostically distinct patient groups.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.